BIO Asia–Taiwan 2022 亞洲生技大會

BIO Asia–Taiwan 2022 亞洲生技大會

TEACHER

Sharon Chan

Session 8 – Healthcare Innovation Strategy

Date:28 July (Thursday)
Time:  12:20 – 13:50 (GMT+8)

Sharon Chan

Head of Johnson & Johnson Innovation – JLABS, Asia Pacific

Sharon is a passionate and respected global health leader with extensive experience in business and product development across pharmaceuticals, medical devices, vaccines and technology platforms.   As Head of JLABS @ Shanghai, Sharon is responsible for setting the strategic direction and overseeing all operational activities for JLABS @ Shanghai, the first Johnson & Johnson Innovation – JLABS in Asia Pacific and the largest in its global network.  In 2020, Sharon was recognized by Forbes China as one of the 50 Top Women in Tech.
 
Prior to joining Johnson & Johnson, Sharon was Head of Asia at Aeras in Beijing.   She had previously served as a member of the Senior Leadership team for Baxter in Shanghai and she began her career working in Business Development for Sosei Heptares in London.
 
Sharon received a Master Degree in Public Health (MPH) at Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; a Master Degree in Business Administration (EMBA) at IE Business School, Madrid, Spain; a Doctorate Degree in Biochemistry and Cardiovascular Medicine (DPhil) at University of Oxford, UK; and a Master Degree in Molecular Biology and Cellular Biochemistry (MBioChem) at University of Oxford, UK.
 

Speech title & Synopsis

Advancing New Healthcare Solutions through Collaboration

Providing a brief introduction to Johnson & Johnson Innovation and how we aim to partner to accelerate life science innovation.